Novel regulators of the in vitro release of hypothalamic corticotrophin-releasing hormone two decades after its discovery: A review

Functional Neurology

Volumn 16, Issue 4 SUPPL., 2001, Pages 205-216

  Costa, Alfredo ^a   Nappi, Rossella E ^a   Smeraldi, Antonella ^a   Bergamaschi, Matteo ^a   Navarra, Pierluigi ^a   Grossman, Ashley ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

AVP; CRH; Hypothalamus; In vitro; Neuropeptides; Stress

Indexed keywords

ARGIPRESSIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; GLYCOPROTEIN GP 120; HYDROCORTISONE; LEPTIN; NEUROPEPTIDE; NEUROTRANSMITTER; GLYCOPROTEIN; GP120 BRAIN GLYCOPROTEIN, BOS TAURUS; NERVE PROTEIN;

COMPARATIVE STUDY; CONFERENCE PAPER; CORTICOTROPIN RELEASE; DRUG ABUSE; HUMAN; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IN VITRO STUDY; NEUROMODULATION; SIGNAL TRANSDUCTION; STRESS; ANIMAL; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; GLYCOPROTEINS; HUMANS; HYPOTHALAMUS; LEPTIN; NERVE TISSUE PROTEINS;

EID: 0035544930     PISSN: 03935264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (78)

1. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin
2. Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat
3. Neurocircuitry of stress: Central control of the hypothalamo-pituitary-adrenocortical axis
4. The role of CRH in behavioral responses to stress
5. Peripheral CRH and urocortin in the control of the immune response
6. Expression cloning of a human corticotropin releasing factor receptor
7. Identification of a seven transmembrane helix receptor for CRF and sauvagine in mammalian brain
8. Cloning and functional expression of a rat brain CRF receptor
9. Animal models of CRH excess and CRH receptor deficiency display altered adaptation to stress
10. A feedback-controlled ensemble model of the stress-responsive hypothalamo-pituitary-adrenal axis
11. Determination of direct effects of cytokines on release of neuropeptides from rat hypothalamus by an in vitro method
12. Regulation of corticotropin-releasing hormone in vitro
13. Release of corticotropin-releasing factor from rat brain regions in vitro
14. Predominant release of vasopressin vs. corticotropin-releasing factor from the isolated median eminence after adrenalectomy
15. In vitro study of immunoreactive corticotropin-releasing factor release from the rat hypothalamus
16. Effect of cholinergic agonists and antagonists on rat hypothalamic corticotropin-releasing hormone secretion
17. Glucose modulation of somatostatin in LHRH release from rat hypothalamic fragments in vitro
18. Effect on various putative neurotransmitters on the secretion of corticotrophin-releasing hormone from the rat hypothalamus in vitro - A model of the neurotransmitters involved
19. Stimulation electrically and by acetylcholine of the rat hypothalamus in vitro
20. The regulation of hypothalamic corticotropin-releasing factor release: In vitro studies
21. Gaseous transmitters as new agents in neuroendocrine regulation
22. Role of nitric oxide and carbon monoxide in modulating the ACTH response to immune and nonimmune signals
23. Nitric oxide and neuroendocrine function
24. The roles of carbon monoxide and nitric oxide in the control of the neuroendocrine stress axis: Complementary or redundant
25. The corticotropin-releasing hormone system in the regulation of energy balance in obesity
26. Neuroendocrine regulation and actions of leptin
27. Weight-reducing effects of the plasma protein encoded by the obese gene
28. Role of leptin in fat regulation
29. Corticotropin-releasing factor modulates dietary preference in nutritionally and physically stressed rats
30. Thermogenic effects of the antiglucocorticoid RU-486 in the rat: Involvement of corticotropin-releasing factor and sympathetic activation of brown adipose tissue
31. Identification of targets of leptin action in rat hypothalamus
32. Stimulation of corticotrophin-releasing hormone release by the obese (ob) gene product, leptin, from hypothalamic explants
33. Corticotropin-releasing factor and adrenocorticotrophic hormone as potential central mediators of OB effects
34. Leptin rapidly inhibits hypothalamic neuropeptide Y secretion and stimulates corticotropin-releasing hormone secretion in adrenalectomized mice
35. Metabolic, gastrointestinal, and CNS neuropeptide effects of brain leptin administration in the rat
36. Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin
37. Centrally administered murine-leptin stimulates the hypothalamus-pituitary- adrenal axis through arginine-vasopressin
38. Leptin stimulates prostaglandin E2 and F2alpha, but not nitric oxide production in neonatal rat hypothalamus
39. Leptin effects on the expression of type-2 CRH receptor mRNA in the ventromedial hypothalamus in the rat
40. Peptides crossing the blood-brain barrier: Some unusual observations
41. Central leptin stimulates corticosterone secretion at the onset of the dark phase
42. Cytokines, leptin, and the hypothalamo-pituitary-adrenal axis
43. Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks
44. Food intake-induced leptin secretion modulates hypothalamo-pituitary-adrenal axis response and hypothalamic Ob-Rb expression to insulin administration
45. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice
46. Glutamate neurotoxicity and disease of the nervous system
47. HIV glycoprotein (gp120) infused into rat brain induces interleukin-1 to elevate pituitary-adrenal activity and decrease peripheral cellular immune responses
48. Involvement of interleukin-1b in the mechanism of human immunodeficiency virus type 1 (HIV-1) recombinant protein gp120-induced apoptosis in the neocortex of rat
49. The HIV envelope protein gp120 in the nervous system: Interactions with nitric oxide, interleukin-1beta and nerve growth factor signalling, with pathological implications in vivo and in vitro
50. Apoptosis induced by gp120 in rat neocortex involves COX-2 and is prevented by NMDA receptor antagonists
51. Neuronal loss in the frontal cortex in HIV infection
52. Dementia associated with the acquired immunodeficiency syndrome
53. Glucocorticoids and the immune system in AIDS
54. The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product
55. Adrenal functin in HIV infected patients
56. Hypothalamic-pituitary-adrenal function in non-AIDS patients with advanced HIV infection
57. Altered adrenocorticotropin and cortisol response to corticotropin-releasing hormone in HIV-1 infection
58. Hypothalamo-pituitary-adrenal function in human immunodeficiency virus-infected men
59. Central nervous system expression of HIV-1 gp120 activates the hypothalamic-pituitary-adrenal axis: Evidence for the involvement of NMDA receptors and nitric oxide synthase
60. Stimulting effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: Involvement of nitric oxide
61. HIV-1 gp120 modulates corticotropin-releasing factor synthesis and release via the stimulation of its mRNA from the rat hypothalamus in vitro: Involvement of inducible nitric oxide synthase
62. HIV-1 protein gp120 crosses the blood-brain barrier: Role of adsorptive endocytosis
63. Human HIV-1 envelope proteins induced interleukin-1, tumor necrosis factor alpha, and nitric oxide in glial cultures derived from fetal, neonatal, and adult human brain
64. The effects of the HIV-1 envelope protein gp120 on the production of nitric oxide and proinflammatory cytokines in mixed glial cell cultures
65. Nitric oxide modulates the release of corticotropin-releasing hormone from the rat hypothalamus in vitro
66. Nitric oxide modulates the release of vasopressin from rat hypothalamic explants
67. Nitric oxide stimulates ACTH secretion and the transcription of the gees encoding for NGFIB, corticotropin-releasing factor, corticotropin-releasing factor receptor type 1, and vasopressin in the hypothalamus of the intact rat
68. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: Actions and mechanisms of action
69. Interleukin-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway
70. Interleukin-1b and interleukin-6 stimulate neurohypophyseal hormone release in vitro
71. Quantitative mapping of glutamate presynaptic terminals in the supraoptic nucleus and surrounding hypothalamus
72. Differential effects of neuroexcitatory aminoacids on CRH-41 and vasopressin release from rat hypothalamic explants
73. Glucocorticoids and immune function: Physiological relevance and pathogenic potential of hormonal dysfunction
74. Endocrine modulation of the neurotoxicity of gp120: Implications for AIDS-related dementia complex
75. Glucocorticoids exacerbate the deleterius effects of gp120 in hippocampal and cortical explants
76. Acquired immune deficiency syndrome: The glucocorticoid solution